HENDERSON, NV, June 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – United Health Products, Inc. (OTCPK: UEEC) (UHP), today announced a final settlement...
Henderson, NV, May 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its FDA...
Henderson, NV, April 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC), (UHP) today provided an update on its...
HENDERSON, NV / ACCESSWIRE / June 28, 2021 / United Health Products, Inc. (OTCPK:UEEC), ('UHP'), developer, manufacturer and marketer of HemoStyp, a patented Neutralized Oxidized Regenerated Cellulose...
United Health Products, Inc. (OTCPK: UEEC), (“UHP” or the “Company”), developer, manufacturer and marketer of HemoStyp®, a patented Neutralized Oxidized Regenerated Cellulose hemostatic agent,...
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), developer of HemoStyp, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent, today announced the publication...
United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), developer, manufacturer and marketer of HemoStyp®, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent,...
United Health Products, Inc. (OTC: UEEC), (“UHP” or the "company”), developer, manufacturer and marketer of HemoStyp®, a patented Neutralized Oxidized Regenerated Cellulose (NORC) hemostatic agent,...
United Health Products, Inc. (OTC: UEEC) (“UHP” or the “Company”), developer, manufacturer and marketer of HemoStyp, a patented Oxidized Regenerated Cellulose (ORC), today announced that the Journal...
United Health Products, Inc. (OTC: UEEC) (“UHP” or the “Company”), today announced that it has filed a non-provisional patent application with the U.S. Patent & Trademark Office for the hydrocolloid...